Exact Mass: 437.1539808000001

Exact Mass Matches: 437.1539808000001

Found 88 metabolites which its exact mass value is equals to given mass value 437.1539808000001, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

7-(1,2,3,4,4a,5,7,7a-Octahydropyrrolo[3,4-b]pyridin-6-yl)-1-cyclopropyl-6-fluoranyl-8-methoxy-4-oxidanylidene-quinoline-3-carboxylic acid hydrochloride

7-(1,2,3,4,4a,5,7,7a-Octahydropyrrolo[3,4-b]pyridin-6-yl)-1-cyclopropyl-6-fluoranyl-8-methoxy-4-oxidanylidene-quinoline-3-carboxylic acid hydrochloride

C21H25ClFN3O4 (437.15175320000003)


   

Estromustine

(13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl) N,N-bis(2-chloroethyl)carbamate

C23H29Cl2NO3 (437.15243840000005)


   

Pazopanib

5-({4-[(2,3-dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl}amino)-2-methylbenzene-1-sulfonamide

C21H23N7O2S (437.1633858)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C93259 - VEGFR Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163953 - VEGFR-targeting Agent C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164037 - PDGFR-targeting Agent C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163999 - cKIT-targeting Agent C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C159198 - c-KIT Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164035 - FGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C155727 - FGFR Inhibitor

   

jatropham 5-O-3)-beta-D-glucopyranoside>|Jatropham 5-O-beta-D-glucopyranosyl-(1->3)-beta-D-glucopyranoside

jatropham 5-O-3)-beta-D-glucopyranoside>|Jatropham 5-O-beta-D-glucopyranosyl-(1->3)-beta-D-glucopyranoside

C17H27NO12 (437.1533182)


   
   
   

Pazopanib

Pazopanib

C21H23N7O2S (437.1633858)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C93259 - VEGFR Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163953 - VEGFR-targeting Agent C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164037 - PDGFR-targeting Agent C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163999 - cKIT-targeting Agent C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C159198 - c-KIT Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164035 - FGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C155727 - FGFR Inhibitor

   

Cys Cys Gly Arg

(2S)-2-{2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]acetamido}-5-carbamimidamidopentanoic acid

C14H27N7O5S2 (437.1515012)


   

Cys Cys Arg Gly

2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-5-carbamimidamidopentanamido]acetic acid

C14H27N7O5S2 (437.1515012)


   

Cys Gly Cys Arg

(2S)-2-[(2R)-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}-3-sulfanylpropanamido]-5-carbamimidamidopentanoic acid

C14H27N7O5S2 (437.1515012)


   

Cys Gly Arg Cys

(2R)-2-[(2S)-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}-5-carbamimidamidopentanamido]-3-sulfanylpropanoic acid

C14H27N7O5S2 (437.1515012)


   

Cys Asn Thr Thr

(2S,3R)-2-[(2S,3R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-hydroxybutanamido]-3-hydroxybutanoic acid

C15H27N5O8S (437.1580262)


   

Cys Gln Ser Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-carbamoylbutanamido]-3-hydroxypropanamido]-3-hydroxybutanoic acid

C15H27N5O8S (437.1580262)


   

Cys Gln Thr Ser

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-carbamoylbutanamido]-3-hydroxybutanamido]-3-hydroxypropanoic acid

C15H27N5O8S (437.1580262)


   

Cys Arg Cys Gly

2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-5-carbamimidamidopentanamido]-3-sulfanylpropanamido]acetic acid

C14H27N7O5S2 (437.1515012)


   

Cys Arg Gly Cys

(2R)-2-{2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-5-carbamimidamidopentanamido]acetamido}-3-sulfanylpropanoic acid

C14H27N7O5S2 (437.1515012)


   

Cys Ser Gln Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxypropanamido]-4-carbamoylbutanamido]-3-hydroxybutanoic acid

C15H27N5O8S (437.1580262)


   

Cys Ser Thr Gln

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxypropanamido]-3-hydroxybutanamido]-4-carbamoylbutanoic acid

C15H27N5O8S (437.1580262)


   

Cys Thr Asn Thr

(2S,3R)-2-[(2S)-2-[(2S,3R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxybutanamido]-3-carbamoylpropanamido]-3-hydroxybutanoic acid

C15H27N5O8S (437.1580262)


   

Cys Thr Gln Ser

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxybutanamido]-4-carbamoylbutanamido]-3-hydroxypropanoic acid

C15H27N5O8S (437.1580262)


   

Cys Thr Ser Gln

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxybutanamido]-3-hydroxypropanamido]-4-carbamoylbutanoic acid

C15H27N5O8S (437.1580262)


   

Cys Thr Thr Asn

(2S)-2-[(2S,3R)-2-[(2S,3R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxybutanamido]-3-hydroxybutanamido]-3-carbamoylpropanoic acid

C15H27N5O8S (437.1580262)


   
   
   

Gly Cys Cys Arg

(2S)-2-[(2R)-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]-3-sulfanylpropanamido]-5-carbamimidamidopentanoic acid

C14H27N7O5S2 (437.1515012)


   

Gly Cys Arg Cys

(2R)-2-[(2S)-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]-5-carbamimidamidopentanamido]-3-sulfanylpropanoic acid

C14H27N7O5S2 (437.1515012)


   

Gly Arg Cys Cys

(2R)-2-[(2R)-2-[(2S)-2-(2-aminoacetamido)-5-carbamimidamidopentanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C14H27N7O5S2 (437.1515012)


   

Met Asn Ser Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-carbamoylpropanamido]-3-hydroxypropanamido]-3-hydroxypropanoic acid

C15H27N5O8S (437.1580262)


   

Met Ser Asn Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-hydroxypropanamido]-3-carbamoylpropanamido]-3-hydroxypropanoic acid

C15H27N5O8S (437.1580262)


   

Met Ser Ser Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-hydroxypropanamido]-3-hydroxypropanamido]-3-carbamoylpropanoic acid

C15H27N5O8S (437.1580262)


   

Asn Cys Thr Thr

(2S,3R)-2-[(2S,3R)-2-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-hydroxybutanamido]-3-hydroxybutanoic acid

C15H27N5O8S (437.1580262)


   

Asn Met Ser Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-4-(methylsulfanyl)butanamido]-3-hydroxypropanamido]-3-hydroxypropanoic acid

C15H27N5O8S (437.1580262)


   

Asn Ser Met Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanamido]-4-(methylsulfanyl)butanamido]-3-hydroxypropanoic acid

C15H27N5O8S (437.1580262)


   

Asn Ser Ser Met

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanamido]-3-hydroxypropanamido]-4-(methylsulfanyl)butanoic acid

C15H27N5O8S (437.1580262)


   

Asn Thr Cys Thr

(2S,3R)-2-[(2R)-2-[(2S,3R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxybutanamido]-3-sulfanylpropanamido]-3-hydroxybutanoic acid

C15H27N5O8S (437.1580262)


   

Asn Thr Thr Cys

(2R)-2-[(2S,3R)-2-[(2S,3R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxybutanamido]-3-hydroxybutanamido]-3-sulfanylpropanoic acid

C15H27N5O8S (437.1580262)


   

Gln Cys Ser Thr

(2S,3R)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-sulfanylpropanamido]-3-hydroxypropanamido]-3-hydroxybutanoic acid

C15H27N5O8S (437.1580262)


   

Gln Cys Thr Ser

(2S)-2-[(2S,3R)-2-[(2R)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-sulfanylpropanamido]-3-hydroxybutanamido]-3-hydroxypropanoic acid

C15H27N5O8S (437.1580262)


   

Gln Ser Cys Thr

(2S,3R)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-hydroxypropanamido]-3-sulfanylpropanamido]-3-hydroxybutanoic acid

C15H27N5O8S (437.1580262)


   

Gln Ser Thr Cys

(2R)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-hydroxypropanamido]-3-hydroxybutanamido]-3-sulfanylpropanoic acid

C15H27N5O8S (437.1580262)


   

Gln Thr Cys Ser

(2S)-2-[(2R)-2-[(2S,3R)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-hydroxybutanamido]-3-sulfanylpropanamido]-3-hydroxypropanoic acid

C15H27N5O8S (437.1580262)


   

Gln Thr Ser Cys

(2R)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-hydroxybutanamido]-3-hydroxypropanamido]-3-sulfanylpropanoic acid

C15H27N5O8S (437.1580262)


   

Arg Cys Cys Gly

2-[(2R)-2-[(2R)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]acetic acid

C14H27N7O5S2 (437.1515012)


   

Arg Cys Gly Cys

(2R)-2-{2-[(2R)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-sulfanylpropanamido]acetamido}-3-sulfanylpropanoic acid

C14H27N7O5S2 (437.1515012)


   

Arg Gly Cys Cys

(2R)-2-[(2R)-2-{2-[(2S)-2-amino-5-carbamimidamidopentanamido]acetamido}-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C14H27N7O5S2 (437.1515012)


   

Ser Cys Gln Thr

(2S,3R)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-sulfanylpropanamido]-4-carbamoylbutanamido]-3-hydroxybutanoic acid

C15H27N5O8S (437.1580262)


   

Ser Cys Thr Gln

(2S)-2-[(2S,3R)-2-[(2R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-sulfanylpropanamido]-3-hydroxybutanamido]-4-carbamoylbutanoic acid

C15H27N5O8S (437.1580262)


   

Ser Met Asn Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-(methylsulfanyl)butanamido]-3-carbamoylpropanamido]-3-hydroxypropanoic acid

C15H27N5O8S (437.1580262)


   

Ser Met Ser Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-(methylsulfanyl)butanamido]-3-hydroxypropanamido]-3-carbamoylpropanoic acid

C15H27N5O8S (437.1580262)


   

Ser Asn Met Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanamido]-4-(methylsulfanyl)butanamido]-3-hydroxypropanoic acid

C15H27N5O8S (437.1580262)


   

Ser Asn Ser Met

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanamido]-3-hydroxypropanamido]-4-(methylsulfanyl)butanoic acid

C15H27N5O8S (437.1580262)


   

Ser Gln Cys Thr

(2S,3R)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-carbamoylbutanamido]-3-sulfanylpropanamido]-3-hydroxybutanoic acid

C15H27N5O8S (437.1580262)


   

Ser Gln Thr Cys

(2R)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-carbamoylbutanamido]-3-hydroxybutanamido]-3-sulfanylpropanoic acid

C15H27N5O8S (437.1580262)


   

Ser Ser Met Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxypropanamido]-4-(methylsulfanyl)butanamido]-3-carbamoylpropanoic acid

C15H27N5O8S (437.1580262)


   

Ser Ser Asn Met

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxypropanamido]-3-carbamoylpropanamido]-4-(methylsulfanyl)butanoic acid

C15H27N5O8S (437.1580262)


   

Ser Thr Cys Gln

(2S)-2-[(2R)-2-[(2S,3R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxybutanamido]-3-sulfanylpropanamido]-4-carbamoylbutanoic acid

C15H27N5O8S (437.1580262)


   

Ser Thr Gln Cys

(2R)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxybutanamido]-4-carbamoylbutanamido]-3-sulfanylpropanoic acid

C15H27N5O8S (437.1580262)


   

Thr Cys Asn Thr

(2S,3R)-2-[(2S)-2-[(2R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-hydroxybutanoic acid

C15H27N5O8S (437.1580262)


   

Thr Cys Gln Ser

(2S)-2-[(2S)-2-[(2R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-sulfanylpropanamido]-4-carbamoylbutanamido]-3-hydroxypropanoic acid

C15H27N5O8S (437.1580262)


   

Thr Cys Ser Gln

(2S)-2-[(2S)-2-[(2R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-sulfanylpropanamido]-3-hydroxypropanamido]-4-carbamoylbutanoic acid

C15H27N5O8S (437.1580262)


   

Thr Cys Thr Asn

(2S)-2-[(2S,3R)-2-[(2R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-sulfanylpropanamido]-3-hydroxybutanamido]-3-carbamoylpropanoic acid

C15H27N5O8S (437.1580262)


   

Thr Asn Cys Thr

(2S,3R)-2-[(2R)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-hydroxybutanoic acid

C15H27N5O8S (437.1580262)


   

Thr Asn Thr Cys

(2R)-2-[(2S,3R)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-carbamoylpropanamido]-3-hydroxybutanamido]-3-sulfanylpropanoic acid

C15H27N5O8S (437.1580262)


   

Thr Gln Cys Ser

(2S)-2-[(2R)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-carbamoylbutanamido]-3-sulfanylpropanamido]-3-hydroxypropanoic acid

C15H27N5O8S (437.1580262)


   

Thr Gln Ser Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-carbamoylbutanamido]-3-hydroxypropanamido]-3-sulfanylpropanoic acid

C15H27N5O8S (437.1580262)


   

Thr Ser Cys Gln

(2S)-2-[(2R)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxypropanamido]-3-sulfanylpropanamido]-4-carbamoylbutanoic acid

C15H27N5O8S (437.1580262)


   

Thr Ser Gln Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxypropanamido]-4-carbamoylbutanamido]-3-sulfanylpropanoic acid

C15H27N5O8S (437.1580262)


   

Thr Thr Cys Asn

(2S)-2-[(2R)-2-[(2S,3R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxybutanamido]-3-sulfanylpropanamido]-3-carbamoylpropanoic acid

C15H27N5O8S (437.1580262)


   

Thr Thr Asn Cys

(2R)-2-[(2S)-2-[(2S,3R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxybutanamido]-3-carbamoylpropanamido]-3-sulfanylpropanoic acid

C15H27N5O8S (437.1580262)


   

Moxifloxacin HCl

Moxifloxacin hydrochloride

C21H25ClFN3O4 (437.15175320000003)


D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D004791 - Enzyme Inhibitors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   
   
   
   

Fmoc-3 (1 naphthyl)-L alanine; Fmoc-1-Nal-OH

Fmoc-3 (1 naphthyl)-L alanine; Fmoc-1-Nal-OH

C28H23NO4 (437.16269980000004)


   
   

2-(9H-FLUOREN-9-YLMETHOXYCARBONYLAMINO)-3-NAPHTHALEN-2-YL-PROPIONIC ACID

2-(9H-FLUOREN-9-YLMETHOXYCARBONYLAMINO)-3-NAPHTHALEN-2-YL-PROPIONIC ACID

C28H23NO4 (437.16269980000004)


   

3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-Methoxy-7-[(4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-, hydrochloride (1:1), rel-

3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-Methoxy-7-[(4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-, hydrochloride (1:1), rel-

C21H25ClFN3O4 (437.15175320000003)


   

1,3-Dimethyl-8-[methyl-(phenylmethyl)amino]-7-[2-(2-pyrimidinylthio)ethyl]purine-2,6-dione

1,3-Dimethyl-8-[methyl-(phenylmethyl)amino]-7-[2-(2-pyrimidinylthio)ethyl]purine-2,6-dione

C21H23N7O2S (437.1633858)


   

1-(3-(2,4-Dimethylthiazol-5-YL)-4-oxo-2,4-dihydroindeno[1,2-C]pyrazol-5-YL)-3-(4-methylpiperazin-1-YL)urea

1-(3-(2,4-Dimethylthiazol-5-YL)-4-oxo-2,4-dihydroindeno[1,2-C]pyrazol-5-YL)-3-(4-methylpiperazin-1-YL)urea

C21H23N7O2S (437.1633858)


   

N4-cyclohexyl-N1-ethyl-N4-(2-pyridinylmethyl)benzene-1,4-disulfonamide

N4-cyclohexyl-N1-ethyl-N4-(2-pyridinylmethyl)benzene-1,4-disulfonamide

C20H27N3O4S2 (437.14429020000006)


   
   

1-[(1R)-1-(hydroxymethyl)-7-methoxy-9-methyl-2-methylsulfonyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]-2-methoxyethanone

1-[(1R)-1-(hydroxymethyl)-7-methoxy-9-methyl-2-methylsulfonyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]-2-methoxyethanone

C20H27N3O6S (437.1620482000001)


   

1-[(1S)-1-(hydroxymethyl)-7-methoxy-9-methyl-2-methylsulfonyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]-2-methoxyethanone

1-[(1S)-1-(hydroxymethyl)-7-methoxy-9-methyl-2-methylsulfonyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]-2-methoxyethanone

C20H27N3O6S (437.1620482000001)


   

1-[(1R)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-methylsulfonyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]-2-methoxyethanone

1-[(1R)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-methylsulfonyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]-2-methoxyethanone

C20H27N3O6S (437.1620482000001)


   

1-[(1S)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-methylsulfonyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]-2-methoxyethanone

1-[(1S)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-methylsulfonyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]-2-methoxyethanone

C20H27N3O6S (437.1620482000001)